ID: ALA1630007

Max Phase: Preclinical

Molecular Formula: C14H22O3

Molecular Weight: 238.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCC(O)C#CC#C[C@@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C14H22O3/c1-3-4-5-6-9-13(16)10-7-8-11-14(17)12(2)15/h12-17H,3-6,9H2,1-2H3/t12-,13?,14+/m0/s1

Standard InChI Key:  RJQVCWNXTFJYBM-SMEJFCCLSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 238.33Molecular Weight (Monoisotopic): 238.1569AlogP: 1.07#Rotatable Bonds: 6
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.41CX Basic pKa: CX LogP: 2.24CX LogD: 2.24
Aromatic Rings: 0Heavy Atoms: 17QED Weighted: 0.48Np Likeness Score: 2.18

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source